|
"Long
before it's in the papers"
August 03, 2010
RETURN
TO THE WORLD SCIENCE HOME PAGE
Doctors investigate why man bled green
June 7, 2007
Courtesy The Lancet
and World Science staff
An unusual case of a man who
bled dark green blood during an operation is analysed in in the
June 9 edition of the medical journal The Lancet.
Anaesthesiologists Stephan Schwarz and Alana Flexman of St Paul’s Hospital at The University of British Columbia, Vancouver, Canada and colleagues did the operation and
wrote the case report. It described the situation as follows:
A 42-year-old white Canadian man had developed a condition known as compartment syndrome, involving tissue or nerve damage due to restricted blood flow, in the lower legs after falling asleep sitting. He was a smoker with a history of chronic shoulder pain and migraine, and was on a number of medications.
Doctors decided he needed urgent fasciotomies, a limb saving-procedure that involves cutting into tissue to relieve pressure. Emergency tests revealed a somewhat rapid heart beat, but normal blood pressure. There was one abnormal blood test result, extremely high levels of an enzyme called creatine kinase.
During the surgery, doctors attempted to insert an arterial catheter, a thin flexible tube used to allow introduction or withdrawal of fluids or to keep a passageway open. Several insertion attempts yielded dark greenish-black blood, which was immediately sent away for analysis. The catheter was eventually fully inserted, and the man recovered.
Physicians said the green blood might be due to his very high intake of the migraine drug sumatriptan, which contains sulfur. This could have caused a condition called sulfhaemoglobinaemia, in which a sulfur atom is incorporated into the molecule hemoglobin. Hemoglobin is a protein carried by red
blood cells that functions to pick up oxygen in the lungs and deliver it throughout the body.
Sulfhaemoglobinaemia generally goes away by itself with red blood cell turnover, but blood transfusion can be necessary in severe cases, the researchers wrote.
* * *
Send us a comment
on this story, or send
it to a friend
|
|
|
On
Home Page
LATEST
EXCLUSIVES
-
Report: cells “from space” have unusual makeup
-
Dolphins and the evolution of teaching
-
Drug may trick body into “thinking” you exercised
-
Tit-for-tat: birds found to repay wartime help
-
Musical genes may be coming to light
MORE NEWS
-
Rock-hurling zoo chimp stocked ammo in advance: study
-
Faith found to reduce errors on psychological test
-
Doodling gets its due: tiny artworks may aid memory
-
From oral to moral? Dirty deeds may prompt “bad taste” reaction
|
|
|
|
|
|
|
|
|
An unusual case of a man who produced dark green blood during an operation is analysed in in this week’s edition of the medical journal The Lancet.
Anaesthesiologists Stephan Schwarz and Alana Flexman of St Paul’s Hospital at The University of British Columbia, Vancouver, Canada and colleagues did the operation and authored the case report. It described the situation as follows:
A 42-year-old white Canadian man had developed a condition known as compartment syndrome, involving tissue or nerve damage due to restricted blood flow, in the lower legs after falling asleep sitting. He was a smoker with a history of chronic shoulder pain and migraine, and was on a number of medications.
Doctors decided he needed urgent fasciotomies, a limb saving-procedure that involves cutting into tissue to relieve pressure. Emergency tests revealed a somewhat rapid heart beat, but normal blood pressure. There was one abnormal blood test result, extremely high levels of an enzyme called creatine kinase.
During the surgery, doctors attempted to insert an arterial catheter, a thin flexible tube used to allow introduction or withdrawal of fluids or to keep a passageway open. Several insertion attempts yielded dark greenish-black blood, which was immediately sent away for analysis. The catheter was eventually fully inserted, and the man recovered.
Physicians said the green blood might be due to his very high intake of the migraine drug sumatriptan, which contains sulfur. This could have caused a condition called sulfhaemoglobinaemia, in which a sulfur atom is incorporated into the molecule hemoglobin. Hemoglobin is a protein carried by red cells that functions to pick up oxygen in the lungs and deliver it throughout the body.
Sulfhaemoglobinaemia generally goes away by itself with red blood cell turnover, but blood transfusion can be necessary in severe cases, the researchers wrote.
|